Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study.

Diagnostics (Basel) · 2025 · PMC11988301 · PMID 40218150

Europe PMC DOI

hedged sentence

0.3200

closest p · 6.4× alpha

0.3200

boldest claim

The sentences

did not reach statistical significancep = 0.32not close (p > 0.1)

As indicated by this curve, the csDMARD-only group generally exhibited a higher rate of ILD worsening than the b/tsDMARD-exposed group; however, this difference did not reach statistical significance ( p = 0.32 via a log-rank test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.